Table 1.
Summary for the Status of Breast Tumor Patients
| Case | Tumor Size (cm) | Stage | Pathology | Black’s Nuclear Grade | ER and/or PR | Her-2/neu | Ki-67 (%) | Treatment before Imaging | Response to Initial treatment | T/N ratio |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3.5 × 4 | II | poorly differentiated invasive ductal carcinoma | 3 | negative | negative | N/A | Genasense | PR | 3.3 |
| 2 | 5 × 5 | III | poorly differentiated invasive ductal carcinoma | 3 | negative | negative | 30 | - | - | 1.7 |
| 3 | 3 × 5 | II | Invasive ductal carcinoma | 2 | positive | negative | 10 | Paclitaxel | CR | 2.1 |
| 4 | 6 × 5 | III | Invasive adeno carcinoma | 2 | positive | negative | 75 | FAC | PR | 2.5 |
| 5 | 3.5 × 4 | II | poorly differentiated invasive ductal carcinoma | 3 | positive | negative | 40 | Paclitaxel | CR | 2.7 |
| 6 | 8 × 6 | III | moderately differentiated infilterating ductal carcinoma | 2 | positive | negative | N/A | - | - | 1.3 |
| 7* | 3.5 × 4 | II | poorly differentiated tumor | 3 | positive | negative | N/A | - | - | N/A |
| 8 | 5 × 4 | III | moderately differentiated infilterating ductal carcinoma | 2 | positive | negative | 90 | - | - | 1.4 |
| 9 | 3 × 4 | II | poorly differentiated infilterating lobular carcinoma | 3 | positive | positive | 35 | - | - | 1.6 |
| 10 | 5 × 5 | III | poorly differentiated invasive ductal carcinoma | 3 | positive | positive | 20 | Genasense | PR | 2.3 |
CR: complete remission, PR: partial remission
*
The data was not available due to colloidal formation in final product